0001140361-14-038522.txt : 20141017 0001140361-14-038522.hdr.sgml : 20141017 20141017204205 ACCESSION NUMBER: 0001140361-14-038522 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141015 FILED AS OF DATE: 20141017 DATE AS OF CHANGE: 20141017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RESMED INC CENTRAL INDEX KEY: 0000943819 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980152841 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: 8587462400 MAIL ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farrell Michael J. CENTRAL INDEX KEY: 0001485164 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15317 FILM NUMBER: 141162851 MAIL ADDRESS: STREET 1: C/O REMED INC STREET 2: 9001 SPECTRUM CTR. BLVD. CITY: SAN DIEGO, STATE: CA ZIP: 92123 FORMER NAME: FORMER CONFORMED NAME: Farrell Michael DATE OF NAME CHANGE: 20100224 4 1 doc1.xml FORM 4 X0306 4 2014-10-15 0 0000943819 RESMED INC RMD 0001485164 Farrell Michael J. RESMED INC. 9001 SPECTRUM CENTER BLVD SAN DIEGO CA 92123 0 1 0 0 Chief Executive Officer ResMed Common Stock 2014-10-15 4 M 0 3200 21.675 A 147046.744 D ResMed Common Stock 2014-10-15 4 S 0 3200 46.612 D 143846.744 D ResMed Common Stock Options 21.675 2014-10-15 4 M 0 3200 0 D 2006-10-01 2015-10-01 ResMed Common Stock 3200 300 D The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended. Represents date options first became exercisable. Options vested 1/3 on the anniversary of the grant. This transaction was executed in multiple trades at prices ranging from $46.36 to $46.77. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer. Michael J. Farrell, Chief Executive Officer 2014-10-17